Integrin alpha 6 regulates glioblastoma stem cells.

Cancer stem cells (CSCs) are a subpopulation of tumor cells suggested to be critical for tumor maintenance, metastasis, and therapeutic resistance. Prospective identification and targeting of CSCs are therefore priorities for the development of novel therapeutic paradigms. Although CSC enrichment has been achieved with cell surface proteins including CD133 (Prominin-1), the roles of current CSC markers in tumor maintenance remain unclear. We examined the glioblastoma stem cell (GSC) perivascular microenvironment in patient specimens to identify enrichment markers with a functional significance and identified integrin alpha6 as a candidate. Integrin alpha6 is coexpressed with conventional GSC markers and enriches for GSCs. Targeting integrin alpha6 in GSCs inhibits self-renewal, proliferation, and tumor formation capacity. Our results provide evidence that GSCs express high levels of integrin alpha6, which can serve not only as an enrichment marker but also as a promising antiglioblastoma therapy.
AuthorsJustin D Lathia, Joseph Gallagher, John M Heddleston, Jialiang Wang, Christine E Eyler, Jennifer Macswords, Qiulian Wu, Amit Vasanji, Roger E McLendon, Anita B Hjelmeland, Jeremy N Rich
JournalCell stem cell (Cell Stem Cell) Vol. 6 Issue 5 Pg. 421-32 (May 7 2010) ISSN: 1875-9777 [Electronic] United States
PMID20452317 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • AC133 antigen
  • Antibodies, Blocking
  • Antigens, CD
  • Biomarkers, Tumor
  • Glycoproteins
  • Integrin alpha6
  • Peptides
  • Animals
  • Antibodies, Blocking (pharmacology)
  • Antigens, CD (metabolism)
  • Biomarkers, Tumor (metabolism)
  • Cell Proliferation (drug effects)
  • Gene Knockdown Techniques
  • Glioblastoma (blood supply, metabolism, pathology)
  • Glycoproteins (metabolism)
  • Humans
  • Integrin alpha6 (metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Neoplastic Stem Cells (drug effects, metabolism, pathology)
  • Neovascularization, Pathologic (metabolism, pathology)
  • Peptides (metabolism)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: